{{Rsnum
|rsid=3777193
|Gene=ELL2
|Chromosome=5
|position=95911056
|Orientation=minus
|GMAF=0.416
|Gene_s=ELL2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 58.1 | 35.5 | 6.5
| HCB | 34.1 | 34.1 | 31.8
| JPT | 51.3 | 33.3 | 15.4
| YRI | 0.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 34.1 | 34.1 | 31.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=G
  |Pval=4E-6
  |OR=.16
  |ORtxt=[0.092-0.227] unit increase
  |OA=1
}}